期刊文献+

不同处方5-Fu胃粘附缓释片的溶出度考察 被引量:1

Dissolution of 5-Fu Sustained Releasing Tablets under Different Formulas
下载PDF
导出
摘要 目的:考察不同处方5-Fu胃粘附缓释片剂的溶出度。方法:采用浆法,以0.1mol·L-1盐酸溶液为溶出递质,转速为100r·min-1,温度为(37.0±0.5)℃,利用紫外分光光度法在265nm的波长处测定,进行累积溶出百分率计算。结果:Carbopol 980 PNF、HPMC、ph101、乳糖四种赋形剂的比例不同,其溶出百分率亦存在差异。结论:不同处方的5-Fu胃粘附缓释片的体外溶出度存在显著差异,应继续对处方进行优化,使6h累积释放率达100%。 This paper studies the dissolution of 5-Fu sustained releasing tablets under different formulas. The paddle method is used. Hydrochloric acid with a concentration of 0.1mol/L is taken as the solvent. The rotational speed is set at 100r/ min, and the temperature 37.0±0.5℃. The absorptivity is registered with an ultraviolet spectrophotometer at a wavelength of 265nm. It is found that dissolution readouts are changed for different concentrations of HPMC, ph101, lactose, and Carbopol 980 PNF. The zero-order kinetic equation, first-order kinetic equation, and Higuchi equation are used to measure the release behavior in vitro. Of them, the combination of Carbopol 980 PNF, HPMC, lactose, and ph101 at a proportion of 3:2:5:5 makes the highest dissolution, which reaches a percentage of 86 six hours after release. It is concluded that there are significant differences between different 5-Fu sustained releasing tablets, in the context of dissolution. It is suggested that formulas shall be further optimized to make the dissolution a full 100%.
出处 《世界科学技术-中医药现代化》 2006年第5期43-45,53,共4页 Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology
基金 黑龙江省教育厅基金项目(10541079):5-Fu胃粘附缓释片的研究 负责人:范玉玲。
关键词 5-FU 缓释片 溶出度 分光光度法 5-Fu, sustained releasing tablets, dissolution, UV method
  • 相关文献

参考文献3

  • 1Chan TCK,Coppoc GL,Zimm SB,et al. Pharmacokinetics of intraperitoneally administered dipycidamole in cancer patients. Cancer Res, 1988, 48:215.
  • 2Goldberg JA,Kerr DJ,Watson DG,et al. The pharmacokinetics of 5-Fluorouracil administered by arterial infusion in advanced colorectal hepatic metastases. Br J Cancer, 1990, 61:913.
  • 3陈碧.HPLC法测定人血清中5-氟尿嘧啶浓度[J].药学进展,2005,29(7):332-334. 被引量:8

二级参考文献6

  • 1李发美.医学高效液相色谱技术[M].北京:人民卫生出版社,1999..
  • 2中华人民共和国卫生部药典委员会.中华人民共和国药典(二部)[Z].北京:化学工业出版社,2000..
  • 3Gamelin E, Celle M. Rapid and sensitive highyperformance liquid chromatographic analysis of halogenopyrimidines in plasma[J]. J Chromatogr B, 1997,695(4) :409-413.
  • 4Joulia M, Pinguet F, Grosse P Y, et al. Determination of 5fluorouracil and its main metaboblites in plasma by highperformance liquid chromatography: application to a pharmacokinetic study[J]. J Chromatogr B, 1997, 692(2):427-430.
  • 5Kuzuya T, Yamachi M, Ito A, et al. Pharmacokinetic characteristics of 5-fluorouracil and mitomyicn C in intraperitoneal chemotherapy[J]. J Pharm Pharmacol, 1994,46(2) :685-688.
  • 6Paroni R, Arcelloi C, De Vechi E, et al. Plasma mitomycin C concentrations determined by HPLC coupled to solid-phase extraction[J]. Clin Chem, 1997, 43(4):615-619.

共引文献7

同被引文献7

  • 1夏祖学,刘长军,闫丽萍,杨晓庆.微波化学的应用研究进展[J].化学研究与应用,2004,16(4):441-444. 被引量:73
  • 2BERGESE P, COLOMBO I,GERVASONI D,et al. Microwavegenerated nanocomposites for making insoluble drugs soluble[J]. Materials Science Engineering C, 2003,23:791 -795.
  • 3KAPPE C 0. Controlled Microwave Heating in Modem OrganicSynthesis [ J ]. Angew. Chem. Int. Ed. , 2004, 43 : 6250 -6284.
  • 4WIESBROCK F, HOOGENBOOM R,SCHUBERT U S. Micro-wave -Assisted Polymer Synthesis : State - of - the - art and Fu-ture Perspectives [ J ] . Macromolecular Rapid Communica -tions,2004, 25:1739-1764.
  • 5KER J S, KOFLER S B. Alternative solvent - free preparationmethods for felodipine surface solid dispersions [ J]. Drug De-velopment and Industrial Pharmacy, 1998, 24(4) :359 -363.
  • 6XIAN H,TAN W F, JING Z J,et al. Preparation and study the1:2 inclusion complex of carvedilol with - cyclodextrin [ J].Journal of Pharmaceutical and Biomedical Analysis,2004,34 :517 -523.
  • 7靖博宇,王志远,李燕,孙进,何仲贵.非洛地平固体分散体的制备和体外溶出度考察[J].沈阳药科大学学报,2010,27(3):185-190. 被引量:22

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部